Related Experiment Video
Updated: Mar 28, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Osteoporosis: A Review
Osteoporosis, a silent disease, significantly raises fracture risk. Early diagnosis and treatment based on bone mineral density (BMD) are crucial to prevent debilitating fractures and associated costs.
Area of Science:
- Gerontology
- Orthopedics
- Endocrinology
Background:
- Osteoporosis is a prevalent condition characterized by reduced bone mineral density (BMD).
- It significantly elevates the risk of fragility fractures, leading to morbidity and healthcare costs.
- Early detection and intervention are vital to mitigate the impact of osteoporosis.
Purpose of the Study:
- To define osteoporosis based on bone mineral density (BMD) criteria.
- To differentiate between normal bone density, osteopenia, and osteoporosis.
- To establish criteria for severe osteoporosis, including the presence of fractures.
Main Methods:
- Bone mineral density (BMD) is assessed and compared to young adult reference values.
- Standard deviations (SD) from the young adult mean are used for classification.
- The presence or absence of fragility fractures is considered for severe osteoporosis diagnosis.
Main Results:
- Normal BMD is within 1 SD of the young adult mean.
- Osteopenia is defined as BMD between 1 and 2.5 SD below the young adult mean.
- Osteoporosis is diagnosed when BMD is greater than 2.5 SD below the young adult mean.
Conclusions:
- Osteoporosis diagnosis relies on standardized BMD measurements.
- Defining severity, including severe osteoporosis, aids in risk stratification and treatment planning.
- Timely management of osteoporosis is essential to prevent fractures and their consequences.
More Related Videos
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
What is the Skeletal System?